Francois Roubille: New ESC Consensus on Inflammation in Coronary Syndromes
Francois Roubille, Head of the Intensive Care Unit at University Hospital of Montpellier, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Heart Journal, adding:
”New ESC consensus on inflammation in coronary syndromes!
Proud to share our new clinical consensus statement on inflammation in coronary syndromes, published in European Heart Journal: Acute Cardiovascular Care, on behalf of several ESC councils and working groups.
We review how inflammation drives the continuum from chronic coronary syndromes to acute coronary syndromes, integrating mechanisms, biomarkers, imaging, and clinical implications.
Key messages include:
- Inflammation is a modifiable but secondary driver of risk in coronary artery disease.
- High-sensitivity CRP is the most practical biomarker for routine clinical use.
- Inflammation assessment should never delay guideline-directed revascularization and prevention.
- Standard therapies and lifestyle changes already exert meaningful anti-inflammatory effects.
- Low-dose colchicine is currently the only widely implementable anti-inflammatory drug in everyday practice, in carefully selected patients.
Beyond summarizing the evidence, the document provides pragmatic guidance on when, how, and in whom to assess and treat inflammation in real-world clinical practice, emphasizing a holistic, patient-centred approach rather than an ‘inflammation-only’ strategy.
I hope this consensus will help colleagues integrate inflammation into coronary care in a balanced way – bridging mechanistic insights, trial data, and daily decision-making.”
Title: Inflammation in coronary syndromes in clinical practice: a clinical consensus statement of the Association for Acute Cardiovascular Care of the European Society of Cardiology, the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases, the European Society of Cardiology Council on Basic Cardiovascular Science, and the European Society of Cardiology Council for Cardiology Practice
Authors: François Roubille, John Alexander Kharlamov, Max Lenz, Rosalinda Madonna, Clément Delmas, Hannah Schaubroeck, Marco Morosin, Johann Wojta, Christophe Vandenbriele, Mathieu Kerneis, George Lazaros, Paul Evans, Kurt Huber, Christian Hassager, Jason Tarkin, Stephane Heymans, Ruxandra Maria Christodorescu, Gal Tsaban, Massimo Imazio, Alessandro Sionis

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series